To gain a better understanding of the downstream molecules and pathways in PLXNB2-mediated tumor cell clustering, we performed an MS-based global proteomics analysis of MDA-MB-231 breast cancer cells in suspension before and after clustering. This evidence concerns the gene PLXNB2 and breast carcinoma.